The Home Medical Equipment industry is highly fragmented, aging-owner-driven, and underpinned by recurring Medicare and Medicaid rental revenue — creating an exceptional roll-up opportunity for disciplined acquirers with healthcare operational expertise.
Find Home Medical Equipment Acquisition TargetsThe Home Medical Equipment industry encompasses providers of durable medical equipment, home oxygen and respiratory therapy products, CPAP and sleep therapy devices, mobility aids, and related services delivered directly to patients in their homes. With an estimated U.S. market size of $55–60 billion and a highly fragmented competitive landscape dominated by independent regional operators, HME presents a compelling roll-up opportunity for experienced acquirers. The vast majority of businesses in this space generate $1M–$5M in annual revenue, are owner-operated, and have never undergone a formal sale process. Driven by an aging U.S. population, a secular shift from hospital-based to home-based care delivery, and increasing demand for respiratory and sleep therapy products, organic revenue growth is structural — not cyclical. Despite this tailwind, persistent Medicare reimbursement compression, escalating accreditation and compliance costs, and an aging owner demographic are pushing independent operators toward exit, creating a steady pipeline of acquirable businesses at reasonable valuations. A well-constructed roll-up strategy in HME can generate significant value through geographic service territory expansion, shared back-office infrastructure, payor contract leverage, and eventual exit to a private equity sponsor or strategic acquirer at a meaningful multiple premium.
Home Medical Equipment is one of the most structurally attractive roll-up targets in the lower middle market for several reasons. First, the industry is exceptionally fragmented — thousands of independent HME providers operate across the U.S. with no single dominant player outside of large nationals like Lincare and Apria, leaving substantial white space for regional platform builders. Second, recurring rental revenue from long-term Medicare and Medicaid patients provides predictable, contracted cash flow that institutional buyers prize. Third, the regulatory moat is real: obtaining Medicare supplier numbers, achieving ACHC or Joint Commission accreditation, and building payor contract networks takes years and creates meaningful barriers to entry that protect acquired assets. Fourth, seller motivation is high — the typical HME owner is 55–70 years old, has operated the business for 10–25 years, and is exhausted by reimbursement compression and compliance burden. These sellers often prioritize employee and patient continuity alongside price, creating room for creative deal structures. Fifth, SBA 7(a) financing is broadly available for HME acquisitions with demonstrated profitability, enabling buyers to deploy capital efficiently in platform building without requiring institutional equity at the outset.
The HME roll-up thesis is built on four interlocking pillars. The first is geographic service territory consolidation — acquiring complementary regional operators to build contiguous coverage maps that support shared delivery infrastructure, technician routing efficiency, and unified referral network development across hospital systems and physician groups. The second is back-office centralization — Medicare and Medicaid billing, prior authorization management, compliance documentation, and accreditation maintenance are cost-intensive functions that do not scale linearly. A platform of three to six acquired businesses can share a centralized billing team, compliance officer, and technology stack (billing software such as Brightree or CPR+) that no individual $2M HME business could afford independently, directly expanding EBITDA margins. The third pillar is payor contract leverage — as a platform grows in covered lives and service territory, it gains negotiating leverage with commercial insurers to improve reimbursement rates and access preferred provider status, reducing dependence on Medicare fee schedules subject to competitive bidding compression. The fourth pillar is product line diversification — individual HME businesses often specialize narrowly in respiratory, sleep therapy, or mobility. Combining operators with complementary product mixes across a shared patient population increases revenue per patient, deepens referral relationships, and reduces single-product reimbursement risk. Together, these pillars support an exit to a regional strategic acquirer or private equity sponsor at 5.5x–7.5x EBITDA, generating a meaningful multiple arbitrage over the 3.5x–5.5x entry multiples typical in the lower middle market.
$1M–$5M annual revenue
Revenue Range
$150K–$750K adjusted EBITDA (10–20% margins typical pre-synergies)
EBITDA Range
Establish the Platform Company
Before acquiring add-ons, the roll-up operator must establish a creditworthy platform entity with sufficient operational infrastructure to absorb subsequent acquisitions. This typically involves acquiring a single HME business with $2M–$5M revenue, clean Medicare billing history, active accreditation, and a management team capable of running day-to-day operations without heavy founder involvement. The platform acquisition should be structured as an asset purchase to avoid inheriting pre-closing billing liabilities, with an SBA 7(a) loan covering 80–90% of acquisition financing. The buyer should immediately invest in centralized billing software, hire or retain a compliance officer, and document all operational processes in preparation for scaling.
Key focus: Acquire a clean, well-documented HME business with active Medicare supplier numbers, ACHC accreditation, and a management layer that can operate independently post-close. Prioritize operational stability over growth in the platform acquisition.
Map the Regional Acquisition Pipeline
Once the platform is stabilized — typically six to twelve months post-close — begin systematically identifying add-on targets within adjacent or complementary service territories. Sources include HME-focused business brokers, state HME association member directories, direct outreach to owner-operators nearing retirement age, and referrals from industry contacts including billing software vendors and accreditation consultants. Prioritize targets with complementary product lines (e.g., if the platform is respiratory-heavy, seek mobility or sleep therapy operators), contiguous geography to enable shared delivery routing, and motivated sellers who will accept creative deal structures including earnouts tied to payor contract retention.
Key focus: Build a proprietary deal pipeline of 10–20 qualified HME targets within a defined regional footprint, prioritizing complementary product mix and service territory adjacency over pure revenue size.
Execute Add-On Acquisitions with Disciplined Structuring
Structure each add-on acquisition as an asset purchase with representations and warranties focused on Medicare billing compliance history, equipment inventory condition, and payor contract transferability. Commission a pre-close Medicare billing audit through a healthcare compliance firm to identify any recoupment exposure before assuming the supplier number. Negotiate payor contract assignment provisions carefully — many commercial insurance contracts require insurer consent for assignment, and failure to secure this can materially impact post-close revenue. Use seller notes (10–20% of purchase price) and earnout provisions tied to referral retention and revenue continuity to align seller incentives through the transition period. Require 6–12 month seller transition support to transfer referral relationships and staff loyalty.
Key focus: Mitigate Medicare billing recoupment risk through pre-close compliance audits, negotiate payor contract assignment rights before closing, and use seller financing structures to align post-close incentives.
Integrate and Centralize Back-Office Operations
Post-acquisition integration is the primary source of margin expansion in an HME roll-up. Migrate all acquired businesses onto a single billing platform (Brightree, CPR+, or equivalent) within 90 days of close to enable centralized claim submission, denial management, and compliance reporting. Consolidate billing staff into a centralized revenue cycle management function, retaining the highest-performing billers from acquired businesses. Implement a shared compliance calendar covering ACHC re-accreditation cycles, OIG exclusion list screening, and Medicare prior authorization tracking across all locations. Centralize equipment procurement to negotiate volume discounts with key suppliers including ResMed, Philips Respironics, and Invacare, reducing cost of goods across the platform.
Key focus: Achieve back-office consolidation within 90–180 days of each add-on close, prioritizing billing platform migration, compliance infrastructure centralization, and procurement cost reduction.
Optimize Payor Mix and Referral Network Development
As the platform grows in scale and geographic coverage, actively renegotiate commercial insurance contracts to improve reimbursement rates above Medicare fee schedules. A platform generating $8M–$15M in combined revenue across three to five locations has meaningful leverage with regional BlueCross BlueShield plans, Aetna, and United Healthcare that no individual $2M operator possesses. Simultaneously, invest in a dedicated referral development representative to deepen relationships with hospital discharge planners, pulmonologists, sleep medicine practices, and home health agencies across the combined service territory. Document referral source performance metrics — referrals per source per month, product category breakdown — to identify high-value relationships and optimize coverage.
Key focus: Leverage combined platform scale to renegotiate commercial payor contracts above Medicare rates and develop a systematic referral relationship management program across all acquired locations.
Prepare for Strategic Exit
A well-constructed HME platform of four to six businesses generating $8M–$20M in combined revenue with centralized back-office operations, diversified payor mix, and documented recurring rental revenue is an attractive acquisition target for regional strategic acquirers, national HME operators, or private equity sponsors seeking a healthcare services platform. Begin exit preparation 18–24 months before target close by commissioning a Medicare billing compliance audit, normalizing financials across all entities onto accrual-basis GAAP statements, and documenting EBITDA bridge from individual business acquisitions to combined platform synergies. Engage an investment bank or M&A advisor with specific HME or healthcare services transaction experience to run a structured sale process targeting 5.5x–7.5x EBITDA on the combined platform.
Key focus: Execute a structured exit process 18–24 months after achieving platform scale, supported by clean compliance records, normalized accrual financials, and demonstrated synergy realization across all acquired locations.
Centralized Medicare and Medicaid Billing Infrastructure
Individual HME businesses at the $1M–$3M revenue level typically rely on a small billing team or outsourced billing service with limited denial management capability, resulting in claim denial rates of 15–25% and significant revenue leakage. A centralized billing team of four to six experienced HME billers serving a platform of five to eight locations can reduce denial rates to below 10%, accelerate days sales outstanding from 60–90 days to 35–50 days, and systematically pursue secondary payor billing (Medicaid crossover claims) that individual operators often leave on the table. This operational improvement alone can add 3–6 percentage points of EBITDA margin across the platform without any revenue growth.
Equipment Procurement Cost Reduction
A fragmented HME operator purchasing oxygen concentrators, CPAP devices, power wheelchairs, and hospital beds as individual entities pays retail or near-retail prices with no volume leverage. A consolidated platform purchasing across five to eight locations can negotiate volume-based pricing agreements with major manufacturers including ResMed, Invacare, and Drive DeVilbiss, reducing equipment procurement costs by 8–15% on high-volume product categories. For a platform with $12M in combined revenue, even a 10% reduction in equipment cost of goods represents $500K–$800K in annualized EBITDA improvement, a meaningful multiple expansion driver.
Shared Delivery and Service Technician Routing
Equipment delivery, setup, and service calls are the primary variable cost driver in HME operations, with delivery labor and vehicle expenses consuming 12–18% of revenue at the individual business level. Geographic consolidation of contiguous service territories enables route optimization across a unified delivery fleet, reducing average drive time per delivery, increasing deliveries per technician per day, and allowing shared on-call coverage for after-hours respiratory equipment service. Fleet management software (e.g., Route4Me, OptimoRoute) deployed across combined operations can reduce delivery cost per call by 15–25%, directly expanding margin on the high-volume respiratory and oxygen product lines.
Commercial Payor Contract Renegotiation
Medicare reimbursement rates under the competitive bidding program have compressed margins on core HME product categories — home oxygen, CPAP, and power mobility — by 30–50% over the past decade, and further reductions remain a policy risk. Building a platform with sufficient geographic coverage and covered-lives volume to negotiate improved commercial insurance reimbursement rates above Medicare fee schedules is a critical margin protection strategy. Regional BlueCross BlueShield plans, Cigna, and Aetna routinely pay 115–140% of Medicare rates to preferred HME network providers, and a platform demonstrating broad service territory coverage and strong quality metrics can secure preferred provider status unavailable to individual small operators.
Recurring Rental Revenue Portfolio Expansion
HME businesses generate fundamentally different cash flow profiles from rental revenue versus one-time equipment sales — rental patients generate monthly recurring billings for the duration of medical necessity, creating a predictable annuity-like revenue stream. Acquisitions that add to the combined rental patient census (particularly long-term oxygen therapy patients and power wheelchair users with chronic conditions) compound the platform's recurring revenue base without proportional increases in sales or marketing cost. Systematically converting acquired businesses' one-time sales customers to rental or rent-to-purchase arrangements where clinically and contractually appropriate further strengthens this recurring revenue base, improving both cash flow predictability and platform valuation multiples at exit.
Accreditation and Compliance Cost Sharing
ACHC and Joint Commission accreditation require ongoing compliance infrastructure — policies and procedures documentation, staff competency tracking, mock surveys, and corrective action management — that consumes significant management time and expense at the individual business level. A roll-up platform can employ a single Director of Compliance and Accreditation across all locations, share a unified policy and procedure library updated centrally, and conduct combined mock surveys that prepare all locations simultaneously. This structure reduces per-location accreditation compliance cost by 40–60% while actually improving compliance quality through dedicated expertise, reducing the risk of audit findings or accreditation lapses that would threaten Medicare billing rights.
A well-executed HME roll-up generating $8M–$20M in combined revenue with 15–22% EBITDA margins, centralized operations, and a clean compliance record is positioned for exit to one of three buyer categories. Regional strategic acquirers — larger HME operators or home health conglomerates seeking to expand service territory — represent the most active buyer segment and typically pay 5.0x–6.5x EBITDA for platforms with demonstrated referral network depth and payor contract diversification. National HME operators such as Lincare, Rotech, or Aerocare periodically acquire regional platforms to fill geographic gaps in their coverage maps and may pay premium multiples for businesses with accreditation in hard-to-enter markets. Private equity sponsors focused on healthcare services represent a third exit pathway, particularly for platforms that have demonstrated a repeatable acquisition and integration model and can serve as a foundation for a larger sponsored roll-up. To maximize exit valuation, platform operators should begin exit preparation 18–24 months before target close: commission a comprehensive Medicare billing compliance audit through a healthcare-specialized firm, normalize all entity financials onto accrual-basis GAAP statements with clean three-year histories, document EBITDA bridge from individual acquisitions to combined synergized performance, and ensure all accreditation certificates are current with no open compliance findings. Engaging an investment banker or M&A advisor with specific HME or healthcare services transaction experience — rather than a generalist business broker — is critical to reaching the right buyer universe and structuring representations and warranties around Medicare billing compliance risk, the most consequential diligence issue in any HME transaction.
Find Home Medical Equipment Roll-Up Targets
Signal-scored acquisition targets matched to your roll-up criteria.
Individual HME businesses at the $1M–$5M revenue level typically trade at 3.5x–5.5x adjusted EBITDA in the lower middle market, depending on the quality of recurring rental revenue, compliance history, and payor mix diversification. A consolidated platform of four to six businesses with centralized operations, demonstrated synergies, and $8M–$20M in combined revenue can exit at 5.5x–7.5x EBITDA, creating substantial multiple arbitrage for the roll-up operator. The quality and durability of recurring Medicare rental revenue is the single most important valuation driver — buyers pay meaningful premiums for HME platforms where 60% or more of revenue comes from long-term rental patients.
In an asset purchase — the standard structure for HME acquisitions — the buyer does not automatically inherit the seller's Medicare supplier number. The buyer must apply for a new Medicare supplier number through the PECOS enrollment system, a process that typically takes 60–120 days and requires proof of active accreditation, a physical business location, and compliance with all applicable Medicare supplier standards. To bridge the revenue gap during enrollment, many deals include a transition services agreement allowing the buyer to temporarily bill under the seller's supplier number with appropriate compliance controls, though this arrangement carries regulatory risk and should be carefully structured with healthcare legal counsel. Buyers should factor Medicare enrollment timeline into their post-close integration plan and negotiate transition support provisions accordingly.
The most consequential compliance risk in any HME acquisition is undisclosed Medicare or Medicaid billing impropriety — claims submitted without adequate documentation of medical necessity, billing for equipment not actually delivered, or systematic upcoding of product categories. These violations can result in retroactive overpayment recoupment demands, Civil Monetary Penalty exposure, and in severe cases, exclusion from Medicare participation, which would effectively eliminate the business's revenue base. Buyers should commission a pre-close Medicare billing audit covering a statistically valid sample of claims across all major product categories, review the seller's history with any Medicare Administrative Contractor (MAC) prepayment or postpayment audits, and obtain representations and warranties (backed by escrow or holdback) covering billing compliance for a lookback period of at least three years. ACHC or Joint Commission accreditation compliance history is a secondary but important risk area — lapsed or at-risk accreditation can trigger Medicare supplier revocation.
Seller transition support is critically important in HME acquisitions, more so than in most lower middle market industries. HME businesses are built on personal referral relationships — hospital discharge planners, pulmonologists, home health agency case managers, and nursing home administrators who send patients to a specific provider often do so based on personal trust in the owner. If the owner exits abruptly, referral volume can decline 20–40% within the first six months, materially impacting post-close revenue. Buyers should negotiate a minimum 6-month transition period with the seller actively making introductions to key referral sources, and structure earnout provisions tied to referral retention metrics to keep the seller financially motivated. For businesses where the owner is the primary referral relationship driver, a 9–12 month transition with graduated earnout milestones is advisable.
SBA 7(a) loans can be used for HME acquisitions and are broadly available for businesses with demonstrated profitability and clean compliance histories. However, SBA borrowers face limitations on using multiple SBA loans simultaneously — the current maximum SBA 7(a) loan amount per borrower is $5 million, which may constrain financing for larger platform acquisitions or rapid multi-acquisition roll-up strategies. Roll-up operators typically use SBA financing for the initial platform acquisition, then transition to conventional bank debt, SBIC financing, or private equity capital for subsequent add-on acquisitions as the platform builds a track record and balance sheet capable of supporting non-SBA lending. Buyers should engage an SBA lender with specific healthcare services transaction experience, as HME acquisitions require specialized underwriting knowledge around Medicare reimbursement revenue quality and compliance risk exposure.
Three technology systems are foundational for an HME roll-up platform. First, a unified HME-specific billing and patient management platform — Brightree and CPR+ are the industry leaders — that supports centralized claim submission, denial management, prior authorization tracking, and rental billing across multiple locations. Second, a document management system for storing and retrieving patient medical records, certificates of medical necessity, and delivery confirmation documentation required to defend Medicare claims under audit. Third, route optimization software for delivery fleet management that enables efficient scheduling and routing across a consolidated service territory. Beyond these core systems, a roll-up platform should invest in a compliance management platform (e.g., Relias or a custom SharePoint-based solution) for policy distribution, staff competency documentation, and accreditation readiness tracking across all locations. Technology standardization is typically the highest-leverage investment a roll-up operator can make in the first 12 months post-acquisition.
More Home Medical Equipment Guides
More Roll-Up Strategy Guides
Build your platform from the best Home Medical Equipment operators on the market — free to start.
Create your free accountNo credit card required
For Buyers
For Sellers